Tissue sealant compositions, vascular closure devices, and uses thereof
US-9433700-B2 · Sep 6, 2016 · US
US9302026B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9302026-B2 |
| Application number | US-201514591265-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jan 7, 2015 |
| Priority date | Jan 28, 2010 |
| Publication date | Apr 5, 2016 |
| Grant date | Apr 5, 2016 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention relates to a fibrin matrix, its preparation and use for effectively sealing a defect in a mucosa or other moist tissue.
Opening claim text (preview).
The invention claimed is: 1. A method for treating or preventing a defect in a moist tissue of a subject in need comprising the steps of: a) providing a component comprising solid fibrinogen, providing a component comprising a solid proteolytic enzyme which is capable of forming fibrin when it reacts with fibrinogen; and providing a liquid fibrin sealant formulation; b) applying an effective amount of the solid components of a) onto at least a part of the moist tissue; and c)…
Human Necessities · mapped topic
Human Necessities · mapped topic
Human Necessities · mapped topic
Human Necessities · mapped topic
Human Necessities · mapped topic
Related publications grouped by family.
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Answers are generated from the same data shown on this page.